ClinConnect ClinConnect Logo
Search / Trial NCT03138200

The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill

Launched by SZEGED UNIVERSITY · Apr 28, 2017

Trial Information

Current as of July 22, 2025

Unknown status

Keywords

Transfusion Scv O2 Hemoglobin

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult (\>18 y)
  • 2. Critically ill anemic but hemodynamically stable patients treated on the ICU in whom transfusion is considered by the attending physician
  • 3. Routine ICU monitoring: invasive blood pressure, CVC, hourly urine output
  • 4. Anemia is defined as Hb\<100 g/L
  • 5. Hemodynamic stability is defined as:
  • 1. heart rate (HR)\<100/min,
  • 2. mean arterial pressure (MAP)\>60 mmHg
  • 3. no or "minimal" requirement of noradrenaline (NA): compensation for sedation not exceeding 5 µg/min
  • 4. stable homeostasis:
  • i. pH: 7.30-7.45 ii. HCO3 \> 20 mmol/L iii. lactate \< 2 mmol/L e. normal hourly urine output for the last 2 hours not facilitated by diuretics: \>0.5ml/kg/h
  • 6. Central venous catheter in situ (position in the v. cava superior confirmed by chest x-ray)
  • Exclusion Criteria:
  • 1. Pregnancy
  • 2. Head injury requiring ICP monitoring guided control of ICP
  • 3. Shock of any origin
  • 4. Patients with heart failure
  • 5. Patients with renal failure

About Szeged University

Szeged University, a prestigious institution located in Hungary, is a leading center for medical and clinical research. With a commitment to advancing health sciences and improving patient outcomes, the university collaborates with various healthcare professionals and institutions to conduct innovative clinical trials. The university's research initiatives are supported by state-of-the-art facilities and a multidisciplinary team, ensuring rigorous methodologies and adherence to ethical standards. Through its clinical trial sponsorship, Szeged University aims to contribute valuable insights to the medical community and enhance therapeutic approaches across diverse health conditions.

Locations

Szeged, Csongrád, Hungary

Budapest, , Hungary

Szeged, , Hungary

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials